This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Blood Glucose Monitoring Devices - Global Strategic Business Report - 2013-2018: Medtronics Dominates The Global CGM Devices Market

DUBLIN, November 13, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/lkxw7x/blood_glucose) has announced the addition of the "Blood Glucose Monitoring Devices - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for  Blood Glucose Monitoring Devices    in US$ Million by the following Product Segments:

- Blood Glucose Strips - Blood Glucose Meters - Lancets.

The report profiles 94 companies including many key and niche players such as:

- Abbott Diabetes Care Inc. - Arkray Inc. - Arkray USA Inc. - Bayer Healthcare - Bionime Corp. - B. Braun Melsungen AG - DexCom Inc. - LifeScan Inc. Medtronic - Nipro Diagnostics Inc. - Nova Biomedical Corporation - Roche Diagnostics Corp. - Terumo Europe NV.

Key Topics Covered:

I. Introduction, Methodology & Product Definitions

II. Executive Summary 1. Industry Overview 2. Market Trends, Issues And Drivers 3. Diabetes - A Macro Perspective 4. Product Overview 5. Product Innovations/Introductions 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective

III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World

IV. Competitive Landscape

Total Companies Profiled: 94 (including Divisions/Subsidiaries - 112 )

  • The United States (54)
  • Canada (6)
  • Japan (7)
  • Europe (22)
  • - France (2)
  • - Germany (4)
  • - The United Kingdom (4)
  • - Italy (1)
  • - Rest of Europe (11)
  • Asia-Pacific (Excluding Japan) (21)
  • Middle East (2)

For more information visit http://www.researchandmarkets.com/research/lkxw7x/blood_glucose

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Glucose Testing

SOURCE Research and Markets

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,949.59 -85.34 -0.47%
S&P 500 2,097.29 -3.11 -0.15%
NASDAQ 5,014.1020 +19.50 0.39%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs